Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orito

Showing results (391-400 of 440) with videos related to

Pageof 44
Sort By:
Journal of Viral Hepatitis|November 13, 2001
Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infectionK Yoshioka, M Kobayashi, E Orito, et al.
Archives of Virology|January 1, 1996
Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patientsT Ohno, M Mizokami, M G Saleh, et al.
The Journal of General Virology|March 11, 2006
Molecular tracing of Japan-indigenous hepatitis E virusesYasuhito Tanaka, Kazuaki Takahashi, Etsuro Orito, et al.
Journal of Medical Virology|June 22, 2006
Molecular epidemiology of hepatitis B virus in the United Republic of TanzaniaIzumi Hasegawa, Yasuhito Tanaka, Fuat Kurbanov, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver diseaseKei Fujiwara, Yasuhito Tanaka, Etsuro Orito, et al.
Rheumatology International|July 14, 2007
Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodiesTakamasa Wayaku, Minoru Hasegawa, Kenzo Kaji, et al.
Cancer Management and Research|January 8, 2013
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinomaShunsuke Nojiri, Atsunori Kusakabe, Kei Fujiwara, et al.
Nature Communications|May 16, 2015
Atomistic design of microbial opsin-based blue-shifted optogenetics toolsHideaki E Kato, Motoshi Kamiya, Seiya Sugo, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanismKazuhide Hayakawa, Keiichi Irie, Kazunori Sano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 20, 2006
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and CEtsuro Orito, Kei Fujiwara, Yasuhito Tanaka, et al.
Pageof 44

Showing results (391-400 of 440) with videos related to

Sort By:
Pageof 44
Journal of Viral Hepatitis|November 13, 2001
Biochemical response to interferon therapy correlates with interferon sensitivity-determining region in hepatitis C virus genotype 1b infectionK Yoshioka, M Kobayashi, E Orito, et al.
Archives of Virology|January 1, 1996
Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patientsT Ohno, M Mizokami, M G Saleh, et al.
The Journal of General Virology|March 11, 2006
Molecular tracing of Japan-indigenous hepatitis E virusesYasuhito Tanaka, Kazuaki Takahashi, Etsuro Orito, et al.
Journal of Medical Virology|June 22, 2006
Molecular epidemiology of hepatitis B virus in the United Republic of TanzaniaIzumi Hasegawa, Yasuhito Tanaka, Fuat Kurbanov, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver diseaseKei Fujiwara, Yasuhito Tanaka, Etsuro Orito, et al.
Rheumatology International|July 14, 2007
Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodiesTakamasa Wayaku, Minoru Hasegawa, Kenzo Kaji, et al.
Cancer Management and Research|January 8, 2013
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinomaShunsuke Nojiri, Atsunori Kusakabe, Kei Fujiwara, et al.
Nature Communications|May 16, 2015
Atomistic design of microbial opsin-based blue-shifted optogenetics toolsHideaki E Kato, Motoshi Kamiya, Seiya Sugo, et al.
Biological & Pharmaceutical Bulletin|September 2, 2009
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via high-mobility group box1-inhibiting mechanismKazuhide Hayakawa, Keiichi Irie, Kazunori Sano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 20, 2006
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and CEtsuro Orito, Kei Fujiwara, Yasuhito Tanaka, et al.
Pageof 44